Skip to main content
Caplight Logo









Pills2Me

Pills2Me

Private
Las Vegas, NevadaHealthcare & Life Scienceshttps://pills2me.com/v2

Last Round

Accelerator

Oct 3, 2024

Est. Valuation

$2M

Total Funding Raised

$295,000

Company Overview

Pills2Me is a health technology company that provides an on-demand prescription delivery platform to improve medication access and adherence.

Sector

Healthcare & Life Sciences

Verticals

Last-Mile Delivery, Pharma Supply Chain, Patient Engagement

Business Model

B2C

Customer Profile

Usage-Based SaaS, Marketplace Commission, Services & Consulting

AI Layer

Application

Keywords

prescription deliverylast-mile deliverypharmacy deliverymedication accessmedication adherencepharmacy logisticsgig economy deliveryon-demand deliverypharmacy APIhealthcare marketplaceuber for pharmacymedication delivery apppharmacy staffingAI assistanthealth tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pills2Me Comparables

Compare Pills2Me with similar companies based on industry and business-model similarity.

Pills2Me comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medzoomer
83%
ScriptDrop
80%
Phox Health
76%

Pills2Me Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorOct 3, 2024
GrantJul 13, 2023
AcceleratorApr 11, 2022
GrantApr 24, 2020

Key People

Founding team and executive leadership

MPH MSc Leonardo Lizbinski

Co-Founder and CTO

Founding Team

Leslie Asanga

CEO and Founder

Founding Team

Pills2Me Investors

Notable investors and investment history

Pills2Me investors
InvestorRounds
TechstarsAccelerator
Jumpstart FoundryAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 30% MoM.

  • Apr 23, 2026

    Monthly visitors grew 34% MoM, reaching 12.2K.

Pills2Me Filings

Explore SEC and related filing metadata, where available.

Pills2Me filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Pills2Me's valuation, stock price, and market status.

Is Pills2Me a public or private company?

Pills2Me is a private company.

What is the current stock price of Pills2Me?

Pills2Me is a private company with no public stock price. No recent secondary market data is available.

How much is Pills2Me worth (valuation)?

Pills2Me's valuation is estimated at $2.0M based on funding round data.

Can I buy Pills2Me stock?

Pills2Me shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Pills2Me's last funding round?

Pills2Me's most recent funding round was Accelerator on October 3, 2024.

Who are the main investors in Pills2Me?

Key investors in Pills2Me include Techstars, Jumpstart Foundry.

Will Pills2Me IPO soon?

No public IPO plans have been announced for Pills2Me.

How can I track Pills2Me secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pills2Me's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLas Vegas, Nevada
Employee Range8
Year Founded2020
Last FundingOct 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?